Another issue with pharmaceutical funding has been the lack of development of new classes of drugs in response to the growth of antibiotic resistance. (scientificamerican.com)
In the case of malaria and TB we are most definitely looking for new classes of drugs. (scientificamerican.com)
In fact, some technology leaps are so great that they enable a whole new class of products, or a whole new market. (entrepreneur.com)